Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: Really safe and effective? Hepatology (Baltimore, Md.) [Hepatology] Journal article

Title	Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: Really safe and effective?
Author(s)	Lo GH
Institution	Department of Medical Education; Digestive Center, E-Da Hospital-I_SHOU University, Kaohsiung, Taiwan.
Source	Hepatology 2009 Jun 15; 50(3):988.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	19714721

Advertise on this site.